J&J announces PPP for Investigational Prophylactic HIV Vaccine
Pharma | News | 0 Comment | 16 Jul, 2019
Johnson & Johnson has announced that Janssen Vaccines & Prevention B.V., one of its Janssen Pharmaceutical Companies, together with a consortium of global partners are preparing to ...Read more
Cipla EU, Jiangsu Acebright enter into Joint Venture
Pharma | News | 0 Comment | 16 Jul, 2019
Cipla (EU) Limited, a U.K.-based wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited and Jiangsu Acebright Pharmaceutical Co. Ltd. have announced that t...Read more
Takeda expands India portfolio of rare disease therapies
Pharma | News | 0 Comment | 15 Jul, 2019
Takeda has announced the launch of its Enzyme Replacement Therapy portfolio for Lysosomal Storage Disorders (LSD) in India in line with its commitment to address the unmet needs of patients...Read more
Bukwang Pharma subsidiary raises 3 billion won
Pharma | News | 0 Comment | 15 Jul, 2019
Contera Pharma, a Danish subsidiary of South Korea based Bukwang Pharmaceutical, has attracted 3 billion won in Series A from Medici Investments. Conterapa expects JM-010, which is und...Read more
Gilead Sciences, Galapagos enter into deal worth $5B
Pharma | News | 0 Comment | 15 Jul, 2019
US based Gilead Sciences and Belgian firm Galapagos have announced that they have entered into a 10-year global research and development collaboration. Through this agreement...Read more
Glenmark & Torrent to co-market diabetic drug in India
Pharma | News | 0 Comment | 12 Jul, 2019
Glenmark Pharmaceuticals Ltd. (Glenmark), and Torrent Pharmaceuticals Limited (Torrent) have announced that they have entered into a non-exclusive sub-licensing agreement to co-market sodiu...Read more
Novena Global Lifecare to expand NOVU Aesthetics and Xingkeduo brands in China and beyond
Pharma | News | 0 Comment | 12 Jul, 2019
Novena Global Lifecare, one of the world's largest integrated medical healthcare and aesthetic companies with over 100 clinics in 20 cities mainly in the Asia Pacific region, has ...Read more
Yuyu Pharma holds campaign for enhancing corporate transparency
Pharma | News | 0 Comment | 12 Jul, 2019
Yuyu Pharma, a Korean pharmaceutical company celebrated its third year of implementing Yuyu's compliance management system by inviting senior management to its "Self-Compliance Day" worksho...Read more
MacroGenics and I-Mab to develop, commercialize Enoblituzumab in China
Pharma | News | 0 Comment | 11 Jul, 2019
MacroGenics, a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, and I-Mab B...Read more
BI announces Dabigatran's safety and efficacy for management of VTE in children
Pharma | News | 0 Comment | 09 Jul, 2019
Boehringer Ingelheim today announced results from two paediatric studies of dabigatran etexilate, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019...Read more
Lupin launches Imatinib Mesylate tablets
Pharma | News | 0 Comment | 09 Jul, 2019
Pharma major Lupin Limited (Lupin) announced the launch of Imatinib Mesylate Tablets, 100 mg (base) and 400 mg (base). Lupin’s alliance partner Natco had received an approval from the...Read more
Daewoong Pharmaceutical introduced the excellence of NABOTA® (Prabotulinumtoxin A)
Pharma | News | 0 Comment | 09 Jul, 2019
Daewoong Pharmaceutical Co., Ltd, a world-leading botulinum toxin manufacturer in Korea, announced its participation in IMCAS Asia 2019 held in Bali, Indonesia from 5-7 July 2019 ...Read more
Wize Pharma retains Lighthouse BioPartners for LO2A
Pharma | News | 0 Comment | 09 Jul, 2019
Wize Pharma, a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders has announced that it has retained Lighthouse BioPartners, LLC a US-based firm speci...Read more
Glenmark receives ANDA approval for Ranolazine Extended-Release Tablets
Pharma | News | 0 Comment | 09 Jul, 2019
Glenmark Pharmaceuticals Inc. has been granted final approval by the United States Food & Drug Administration for Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg, a generic ver...Read more
FSD Pharma closes deal and acquires Prismic Pharmaceuticals
Pharma | News | 0 Comment | 08 Jul, 2019
FSD Pharma and Prismic Pharmaceuticals, a US-based specialty R&D pharmaceutical company has announced that, on June 28, 2019, they finalized the acquisition by FSD ...Read more
GSK opens new pharma manufacturing facilities with S$130M investment
Pharma | News | 0 Comment | 08 Jul, 2019
GSK on 5 July 2019, opens new state-of-the-art manufacturing facilities in Singapore following an S$130m investment. The new facilities are located in GSK’s Jurong site and include tw...Read more
21st Interphex Week Japan: Making the event as one of the largest pharma industry events in Asia
Pharma | Opinion | By Ankit Kankar | 0 Comment | 05 Jul, 2019
5 july 2019 , Tokyo. In Speaking with an official show director of Reed Exhibition , An official summarised an event as below : Close to 45,000 appx individuals and 1280 Appx Exhibi...Read more
21st Interphex Week Japan concludes in Tokyo
Pharma | News | By Ankit Kankar | 0 Comment | 05 Jul, 2019
5 July 2019 , Tokyo . Interphex Japan concludes in Tokyo 45,000 appx Visitors from around the world including all concurrent shows . 1280 Appx Exhibitors from 34 countries of world. 300...Read more